Dr. Reddys News

Allotment of shares on exercise of Employee Stock Options

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 116021.72 Crore) operating in Pharmaceuticals sector.

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015

Disclosure Under Regulation 30 of SEBI (LODR) Regulations, 2015

The Fed minutes confirmed expectations of a rate cut next month, with most policymakers agreeing it would be appropriate if data aligns with forecasts. Market participants are now focused on US initial jobless claims at 6:00 pm IST and Fed Chair Jerome Powell's upcoming remarks at the Jackson Hole Economic Symposium.

The 1QFY25 corporate earnings report revealed both growth and challenges in India’s market. The Nifty50’s earnings rose 4% YoY, aided by companies like HDFC Bank and Tata Motors, despite setbacks from Oil Marketing Companies. The auto sector displayed strong volume growth, while IT services and healthcare sectors met expectations with promising future outlooks.

Nifty achieved a 4% YoY growth in profit after tax (PAT), exceeding Motilal Oswal's 3% estimate, though it's the slowest growth since the pandemic quarter of 2020. Key contributors to this growth were HDFC Bank, Tata Motors, ICICI Bank, Maruti Suzuki, and Tata Consultancy Services (TCS), which together accounted for 127% of the incremental YoY earnings.

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Loss of Share Certificate(s)

Copy of Newspaper Publication

Notice of Postal Ballot

Dr Reddy's Laboratories Ltd has obtained an Establishment Inspection Report from the USFDA for its Duvvada units, now classified as Voluntary Action Indicated. The units underwent an inspection from May 8 to May 17, 2024, which led to a Form 483 with observations. Dr Reddy’s planned to resolve the issues within the given time.

Update on the USFDA inspection at the Company''s formulations manufacturing facilities (FTO -7 & FTO-9) in Duvvada, Visakhapatnam

Allotment of equity shares on exercise of Employee Stock Options

Copy of Newspaper Publication

Schedule of Analyst / Institutional Investor Meeting

Transcript of earnings call conducted on July 27, 2024

License Agreement with JV Company

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Investment in JV Company

Loss of Share Certificate(s)

On Wednesday, the US Federal Reserve maintained its key interest rate at 5.25–5.5% for the eighth consecutive time, as expected, while signaling the possibility of a rate cut in its next meeting in September. From the Nifty stocks, Power Grid Corporation, Coal India, ONGC, HDFC Bank, and Dr Reddy's Laboratories were the top gainers, rising 2-4%. On the other hand, M&M, Tata Steel, Hero MotoCorp, Britannia, and Tata Motors ended with cuts.

Scrutinizers Report

Outcome of 40th AGM, Scrutinizers Report and Voting Results.

Newspaper Advertisement

Press Release

Bandhan Bank on Friday reported 47% growth in its consolidated net profit at Rs 1,063 crore in the first quarter, compared with Rs 721 crore in the last year period.

Audio Recordings of the Earnings call conducted on July 27, 2024

Additionally the company has also announced that each American Depositary Share (ADS) will still represent 1 equity share. As a result, the number of ADSs held by each American Depositary Receipt holder will increase in proportion to the increase in equity shares.

Dr. Reddy's Lab Q1 Results: While announcing the quarterly numbers, the company's board also approved split of equity shares in the ratio of 1:5, which means that 1 existing share will split into 5. The company said its revenue growth during the quarter was largely driven by growth in global generics revenues in North America as well as India.

Investment in wholly owned subsidiary company

Changes in authorization for determination and disclosure of materiality of event or information

Retirement of Ms. Kalpana Morparia, Independent Director of the Company

Outcome of Board Meeting

Unaudited Financial results for the quarter ended June 30, 2024.

Finolex Industries, IEC Education, IFB Industries, J&K Bank, Jaiprakash Power, SBFC Finance, Vishal Fabrics, Spandana Sphoorty, Smruthi Organics, NTPC, Genus Power, Gujarat Cotex among others will also declare their June quarter results.

In the preceding March quarter, Dr Reddy's reported a consolidated net profit growth of 36% year-on-year to Rs 1,307 crore, while revenue from operations rose 12% year-on-year to Rs 7,083 crore.

Stocks that were in focus include names like Dr Reddy's, which fell 0.79%, Suzlon Energy, which rose 5%, and United Spirits, whose shares declined 4.76% on Wednesday.

Schedule of Analyst / Institutional Investor Meetings

Sale of shares of wholly owned subsidiary company